Top

Journal of Neurology

Published in:

01-06-2011 | Letter to the Editors

Meningeal melanocytosis: a possibly useful treatment for a rare primary brain neoplasm

Authors: Júlia Miró, Roser Velasco, Carles Majós, Miguel Gil, Susana Boluda, Jordi Bruna

Published in: Journal of Neurology | Issue 6/2011

Excerpt

Dear Sirs, …

Available only for authorised users

Brat DJ, Perry A (2007) Melanocytic lesions. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system. IARC, Lyon, pp 181–183

Oka H, Kameya T, Hata T, Kawano N, Fuji K, Yada K (1999) Leptomeningeal melanomatosis with multiple cutaneous pigmented nevi: tumor cell proliferation and malignant transformation in an autopsy case. J Neurooncol 44:41–45PubMedCrossRef

Reyes-Mugica M, Chou P, Byrd S, Ray V, Castelli M, Gattuso P et al (1993) Nevomelanocytic proliferations in the central nervous system of children. Cancer 72:2277–2285PubMedCrossRef

Brat DJ, Giannini C, Scheithauer BW, Burger PC (1999) Primary melanocytic neoplasms of the central nervous system. Am J Surg Pathol 23:745–754PubMedCrossRef

Chapman PB, Einhorn LH, Meyers ML, Saxman S, Destro AN, Panageas KS et al (1999) Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastasic melanoma. J Clin Oncol 17:2745–2751PubMed

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996PubMedCrossRef

Middleton MR, Grob JJ, Aaronson N, Fierlbeck G, Tilgen W, Seiter S et al (2000) Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol 18:158–166PubMed

Kaufmann R, Spieth K, Leiter U, Mauch C, von den Driesch P, Vogt T et al (2005) Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from Dermatologic Cooperative Oncology Group. J Clin Oncol 23:9001–9007PubMedCrossRef

Hofmann M, Kiecker F, Wurm R, Schlenger L, Budach V, Sterry W et al (2006) Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases. J Neurooncol 76:59–64PubMedCrossRef

10.

Agarwala SS, Kirkwood JM, Gore M, Dreno B, Thatcher N, Czarnetski B et al (2004) Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study. J Clin Oncol 22:2101–2107PubMedCrossRef

11.

Paul MJ, Summers Y, Calvert AH, Rustin G, Brampton MH, Thatcher N et al (2002) Effect of temozolomide on central nervous system relapse in patients with advanced melanoma. Melanoma Res 12:175–178PubMedCrossRef

12.

Hwu WJ, Lis E, Menell JH, Panageas KS, Lamb LA, Merrell J et al (2005) Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study. Cancer 103:2590–2597.7PubMedCrossRef

13.

Martin-Blondel G, Rousseau A, Boch AL, Cacoub P, Sène D (2009) Primary pineal melanoma with leptomeningeal spreading: case report and review of the literature. Clin Neuropathol 28:387–394PubMed

14.

Chamberlain MC, Glantz M, Groves MD, Wilson WH (2009) Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment. Semin Oncol 36(Suppl 2):S35–S45PubMedCrossRef

15.

Ngo L, Nei M, Glass J (2006) Temozolomide treatment of refractory epilepsy in a patient with an oligodendroglioma. Epilepsia 47:1237–1238PubMedCrossRef

Title: Meningeal melanocytosis: a possibly useful treatment for a rare primary brain neoplasm
Authors: Júlia Miró
Roser Velasco
Carles Majós
Miguel Gil
Susana Boluda
Jordi Bruna
Publication date: 01-06-2011
Publisher: Springer-Verlag
Published in: Journal of Neurology / Issue 6/2011
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-010-5869-9

At a glance: The STEP trials

Springer Medicine

Meningeal melanocytosis: a possibly useful treatment for a rare primary brain neoplasm

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2011

Taste function in patients with Parkinson disease

Postprandial ghrelin response is reduced in patients with Parkinson’s disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson’s disease?

Cerebrovascular disorders: nonfasting triglycerides and stroke, silent ischemia and thrombolysis, and pathogenesis of cervical artery dissection

Communications of the European Neurological Society

Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases

Teleneurology: is it really at a distance?